Chitosan Microparticles and Nanoparticles as Biocompatible Delivery Vehicles for Peptide and Protein-Based Immunocontraceptive Vaccines

Grants

Funding Acknowledgements

This work was supported by the Cooperative Research Centre for Polymers and the National Health & Medical Research Council of Australia. The authors would like to thank Dr. John Walker (Pfizer Inc., Parkville, Victoria, Australia) for provision of the protein-conjugate vaccine.